ADDIS ABABA, May 17 (Xinhua) -- BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. The BGI Health Ethiopia administers Huo-Yan Air Lab inside the premises of Addis Ababa Bole International Airport, Ethiopia's main international hub and Africa's busiest and leading gateway. BGI Health Ethiopia PLC Administration Director Saron Tamirat said the Huo-Yan Air Lab has been producing accurate and precise COVID-19 test results for passengers traveling to China. BGI Health Ethiopia also opened the first Chinese reagent factory in Ethiopia in September 2020, which has a production capacity of 6 million SARS-COV-2 RT PCR detection kits per year. "The company is presently providing its COVID-19 test kits to the public and private diagnostic centers, eventually contributing to the East African country's fight against the COVID-19 pandemic," Tamirat added.

Source: Ethiopian News May 17, 2022 18:44 UTC